Use UniProt O70212 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL3666 Target Snapshot
5-hydroxytryptamine receptor 3A · SINGLE PROTEIN · Cavia porcellus
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13Protein identity stays anchored to UniProt O70212. Use UniProt O70212 as the stable identity anchor, then attach disease evidence before program review.
5-hydroxytryptamine receptor 3A
Review this target as 5-hydroxytryptamine receptor 3A, mapped to UniProt O70212. Sequence length is 490 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats 5-hydroxytryptamine receptor 3A as ChEMBL target CHEMBL3666, mapped to UniProt O70212. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether 5-hydroxytryptamine receptor 3A is the right protein anchor across sources, using UniProt O70212 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | 5-hydroxytryptamine receptor 3A |
| Target Type | SINGLE PROTEIN |
| Organism | Cavia porcellus |
| UniProt | O70212 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | 5-hydroxytryptamine receptor 3A |
| UniProt Accession | O70212 |
| Component Type | Protein |
| Sequence Length | 490 aa |
5-hydroxytryptamine receptor 3A
How to read this target
Review this target as 5-hydroxytryptamine receptor 3A, mapped to UniProt O70212. Sequence length is 490 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL289469 | 8.4 | Ki | 3.981 | Approved |
| CHEMBL4228145 | 7.8 | Kd | 15.85 | Preclinical |
| CHEMBL4225725 | 7.7 | Kd | 19.95 | Preclinical |
| CHEMBL1668031 | 7.7 | Kd | 19.95 | Preclinical |
| CHEMBL1269981 | 7.6 | Kd | 25.12 | Preclinical |
| CHEMBL56564 | 7.52 | Kd | 30.2 | Clinical |
| CHEMBL1668032 | 7.5 | Kd | 31.62 | Preclinical |
| CHEMBL4225302 | 7.4 | Kd | 39.81 | Preclinical |
| CHEMBL184379 | 7.4 | Kd | 39.81 | Preclinical |
| CHEMBL4227570 | 7.3 | Kd | 50.12 | Preclinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
Binding — 20 assays, 27 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| tissue-based format | 17 | 21 | 6.3 |
| single protein format | 2 | 1 | 7.5 |
| assay format | 1 | 5 | 7.6 |
Functional — 13 assays, 48 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| tissue-based format | 13 | 48 | 5.8 |